Plain-English translation of NCT07017868 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at three substances in your blood — uric acid, homocysteine, and a marker called interleukin-17 — to see if they can help doctors detect kidney disease in lupus patients. Right now, doctors often need to do a kidney biopsy (a small tissue sample) to diagnose lupus kidney disease, but this research is exploring whether simple blood tests could do the job instead.
Kidney involvement is one of the most serious complications of lupus, affecting up to 60% of patients, but current methods to diagnose it require invasive procedures. This study exists to find non-invasive blood tests that could help doctors catch kidney disease earlier and improve treatment outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would come in for a study visit where researchers will take a blood sample and collect information about your health history and any lupus symptoms. The study compares blood markers from three groups: people with lupus who have kidney disease, people with lupus without kidney disease, and healthy volunteers. Overall, the study plans to enroll 120 participants.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Egypt